Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.

BACKGROUND: One objective of the Belgian Rare Diseases plan is to improve patients' management using phenotypic tests and, more specifically, the access to those tests by identifying the biochemical analyses used for rare diseases, developing new financing conditions and establishing reference laboratories. METHODS: A feasibility study was performed from May 2015 until August 2016 in order to select the financeable biochemical analyses, and, among them, those that should be performed by reference laboratories. This selection was based on an inventory of analyses used for rare diseases and a su... Mehr ...

Verfasser: Vandevelde, Nathalie M
Vermeersch, Pieter
Devreese, Katrien M J
Vincent, Marie-Françoise
Gulbis, Béatrice
Eyskens, François
Boemer, François
Gothot, André
Van Hoof, Viviane O
Bonroy, Carolien
Stepman, Hedwig
Martens, Geert A
Bossuyt, Xavier
Roosens, Laurence
Smet, Julie
Laeremans, Hilde
Weets, Ilse
Minon, Jean-Marc
Vernelen, Kris
Coucke, Wim
Advisory Board of the Action 1 of the Belgian National Plan for Rare Diseases
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Verlag/Hrsg.: BioMed Central
Schlagwörter: Belgium / Budgets / Diagnostic Tests / Routine / Humans / Laboratories / Rare Diseases / Clinical pathology / Expertise / Financing / Reference laboratories / Reimbursement codes
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28876812
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2078.1/264123